Clinical Trial Update: Effect of GSK704838 In Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of the GSK704838 compound in healthy volunteers. COPD is listed as the related condition, and the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• GSK704838

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED